Tandem Diabetes Care Gets FDA OK for Smallest Durable Insulin Delivery System
11 July 2023 - 11:49PM
Dow Jones News
By Ben Glickman
Tandem Diabetes Care said Tuesday the U.S. Food and Drug
Administration cleared its Tandem Mobi insulin pump for people with
diabetes age six and older.
The San Diego-based diabetes technology company said the Tandem
Mobi, a miniature insulin pump controllable from a mobile app, is
the world's smallest durable insulin-delivery system. Tandem said
it expected a limited release of the product in late 2023, and full
commercial availability by early 2024.
Tandem said the new product features a 200-unit insulin
cartridge, and is small enough to fit in a coin pocket. The product
uses Tandem's Control-IQ technology, an algorithm which deliveries
regular insulin deliveries and predicts glucose levels.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
July 11, 2023 09:34 ET (13:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From May 2024 to Jun 2024
Tandem Diabetes Care (NASDAQ:TNDM)
Historical Stock Chart
From Jun 2023 to Jun 2024
